SELECT Salutation, Firstname, Lastname, FUR_Profile_Image FROM facultyProfile WHERE PersonID = 3754
BBC features research by Kelvin Davies, Ph.D., and Joel Friedman, M.D., Ph.D., that highlights using nanoparticles to treat erectile dysfunction (ED). Their new study in rats employs a drug-delivery system consisting of nanpoparticles encapsulating nitric oxide and/or oral prescription medications to treat ED topically, potentially preventing systemic side effects. The study appears in the September 18th online version of the Journal of Sexual Medicine. Dr. Davies, senior author of the study, is associate professor of urology and Dr. Friedman, co-author of the study, is professor of physiology & biophysics and of medicine. (Monday, September 21, 2009)
More coverage on this storyU.S. News & World Report (originally Healthday News)
The Sunday Times (UK) interviews Kelvin Davies, Ph.D., on his involvement in a study that used an innovative new drug-delivery system—nanoparticles infused with nitric oxide and applied topically---to successfully treat erectile dysfunction in animals. The nanoparticle technology was developed by Joel M. Friedman, M.D., Ph.D., professor of physiology & biophysics and of medicine at Einstein and his son, Adam Friedman, M.D., a resident in dermatology in Einstein’s department of medicine. The findings received extensive press coverage at the annual meeting of the American Urological Association on April 26, 2009. The topical treatment may offer localized therapeutic results with the benefit of a lower dosage and the avoidance of adverse side effects due to systemic absorption. Dr. Davies is associate professor of urology at Einstein. (Sunday, April 26, 2009) read more...
More coverage on this storyCorriere (Italy)